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Abstract
Introduction: Allergic bronchopulmonary aspergillosis (ABPA) is a T-helper cell 2 (Th2) mediated hypersensitive lung disorder in 
response to Aspergillus that usually affects asthmatic and cystic fibrosis (CF) patients. ABPA rarely presents as lung collapse and 
such kind of presentation is very rare in non asthmatic patients. We are presenting a series of three cases in which ABPA presented 
as lobar or total lung collapse. ABPA presenting as opaque hemithorax is a rarity with only a few of them reported in the literature.
Case series — the first case described is a 45-year non-smoker with history suggestive of bronchial asthma and on chest 
radiological examination was found to have opaque right hemithorax. The second case is of 62-year non-smoker non-asthmatic 
patient who presented to us as left lung collapse. The last case is of middle lobe collapse in asthmatic male. All cases ultimately 
were proved to be having ABPA and after treatment showed marked clinical and radiological improvement.
Conclusions: The present case series highlights the need for aggressive approach in diagnosing this treatable condition in cases 
presenting as segmental or total lung collapse. The condition has a good prognosis if detected early. 
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Streszczenie
Wstęp: Alergiczna aspergiloza oskrzelowo-płucna (AAOP) to choroba wywołana nadwrażliwością na antygeny Aspergillus fumi-
gatus. Jest mediowana przez limfocyty pomocnicze Th2 i występuje zazwyczaj u chorych na astmę i mukowiscydozę. Alergiczna 
aspergiloza oskrzelowo-płucna rzadko prowadzi do niedodmy płuc, szczególnie u osób niechorujących na astmę, i w postaci 
całkowitej niedodmy płuca jest wyjątkową rzadkością — w piśmiennictwie przedstawiono tylko pojedyncze przypadki. 
Seria przypadków:  Pierwszy dotyczy 45-letniego chorego na astmę, nigdy niepalącego, u którego w badaniu radiologicznym 
klatki piersiowej uwidoczniono niedodmę  płuca prawego. W drugim przypadku u 62-letniego mężczyzny, również nigdy niepalą-
cego i niechorującego na astmę stwierdzono niedodmę płuca lewego. Natomiast w trzecim wykryto niedodmę płata środkowego 
u mężczyzny chorego na astmę. U wszystkich chorych ustalono rozpoznanie AAOP, a po zastosowaniu odpowiedniego leczenia 
uzyskano poprawę kliniczną i radiologiczną.
Wnioski: Prezentowana  seria przypadków podkreśla potrzebę diagnostyki pod kątem AAOP chorych z obrazem radiologicznym 
niedodmy części lub całego płuca. Choroba cechuje się dobrą odpowiedzią na leczenie i dobrym rokowaniem, szczególnie gdy 
zostanie wcześnie rozpoznana.
Słowa kluczowe: AAOP, alergiczna aspergiloza oskrzelowo-płucna, niedodma płuca, astma
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Introduction
Allergic bronchopulmonary aspergillosis 
(ABPA) is a T-helper cell 2 (Th2) mediated hyper-
sensitive lung disorder in response to Aspergil-
lus fumigatus that affects asthmatic and cystic 
fibrosis (CF) patients [1]. It is one of the most 
frequently recognized manifestation of allergic 
aspergillosis, occurs worldwide and is now seen 
as an important emerging disease in India [2]. 
This potentially destructive lung disease was 
first reported in England in 1952 and since then 
it has been reported from all the continents [3]. 
The first case of ABPA in India was reported in 
1971 [4], subsequently many cases have been 
reported. In 2000, Kumar and Gaur estimated 
that the prevalence of ABPA in patients with 
asthma is 16% [5]. ABPA has been classified 
into ABPA Seropositive (ABPA-S), ABPA-Cen-
tral Bronchiectasis (ABPA-CB) and ABPA Other 
Radiological Findings (ABPA-CB-ORF) based 
on the radiological picture, with both the seve-
rity of the radiological and serologic findings 
increasing from patients with ABPA-S to those 
with ABPA-CB-ORF [6]. ABPA was diagnosed 
in 27.2% of asthmatics attending pulmonary 
clinic at a referral level hospital in north In-
dia. Amongst them 27% were ABPA-S, 33.3% 
ABPA-CB and 39.6% were ABPA-CB-ORF [7]. 
A recent study by Kumar et al found the relative 
incidence of ABPA, ABPA-CB and ABPA-ORF to 
be 22.32, 43.75 and 33.92 percent respectively 
[8]. The chest radiographic findings depend on 
the clinical presentation of the disease. During 
acute exacerbations of the disease, transient and 
fleeting opacities are characteristically found, 
whereas fixed abnormalities are encountered in 
chronic stages of the disease. Common findings 
include consolidation, mucoid impaction of 
bronchi, and areas of atelectasis, whereas rare 
findings include pleural effusion, perihilar bron-
choceles mimicking adenopathy, miliary nodules 
and unilateral lung collapse. Chest radiographic 
findings are non-specific and high resolution 
computed tomography (HRCT) of the chest is the 
radiological investigation of choice in ABPA. The 
findings on chest HRCT include central bron-
chiectasis, mucus plugging with bronchocele 
formation and others [9]. ABPA rarely presents 
as lung collapse and such kind of presentation 
is very rare in non-asthmatic patients. We de-
scribe here three cases, one with complete lung 
collapse in non-asthmatic patient and two cases 
in asthmatic patients, one with complete lung 
collapse and the other with middle lobe collapse.
Case 1
A 45-year-old non-smoker male presented 
to us with 10 year history of episodic cough and 
breathlessness aggravated with change of season. 
He was a known diabetic on regular treatment. 
On examination vitals were within normal range, 
mediastinum was shifted to the right and breath 
sounds were found to be absent on the right 
side. A previous chest radiogram of the patient 
showed total right lung collapse (Fig. 1A). High 
resolution computed tomography (HRCT) showed 
right lung collapse with mediastinal shift to the 
right (Fig. 2A). At presentation patient was on 
antitubercular therapy for the last five months 
based on chest radiogram and lung HRCT while 
Figure 1. Chest radiogram of the patient in case 1, showing (A) 
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Table 1. Diagnostic features of ABPA in each of the three cases
S.No Criteria Case 1 Case 2 Case 3
1 Bronchial asthma Present Absent Present
2 Serum Total IgE* (IU/ml**) 2345 1930 8064
3 Skin prick test against Aspergillus species Positive Positive Positive
4 Specific IgE against Aspergillus Fumigatus (KUA/l)# 56.5 5.02 39.8
5 Specific IgG## against Aspergillus Fumigatus Positive Positive Positive
6 Serum precipitin against Aspergillus Fumigatus Positive Positive Positive
7 Central bronchiectasis Absent Present Present
8 Absolute eosinophil count (per mm3) 2500 2750 150





Figure 2. High resolution computed tomography of the lung of patient in case1 (A, B) Collapsed right lung at presentation with mediastinal shift to 
right (C, D) Re-expanded right lung after treatment
sputum was negative for acid fast bacilli at that 
time. No symptomatic relief was achieved with 
treatment. He was suspected to have ABPA with 
mucus plugging of the right main bronchus due 
to a characteristic intra luminal density in the 
proximal right main bronchus and was diagnosed 
to have ABPA based on the characteristic investi-
gations (Table 1). Chest physiotherapy, oral corti-
costeroids and oral and inhaled bronchodilators 
were started. A reassessment radiogram done after 
five days of therapy showed aeration of the right 
lung, a repeat HRCT lung showed re expansion of 
right lung and evidence of central bronchiectasis 
in the right lung (Figs 1B, 2B). 
Case 2
A 62-year-old non-smoker farmer presented 
with dry cough and intermittent low grade fever 
for the past six months. He was prescribed some 
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Figure 3. Chest radiogram of the patient in Case 2, showing (A) Collapsed left lung at presentation; (B) Re-expanded left lung after bronchoscopy
oral medications and inhaled bronchodilators, 
which did not lead to relief in his symptoms. The-
re was no personal or family history suggestive 
of atopy. He started producing thick white casts 
in sputum along with weight loss after 5 months 
of dry cough. He was admitted to a hospital with 
sudden onset breathlessness and heaviness over 
the left side of chest. On chest radiogram, left 
sided complete lung collapse was present. The 
patient was investigated for pulmonary tuber-
culosis and bronchogenic carcinoma but repe-
ated sputum examinations for acid fast bacilli 
and malignant cells were negative. Because of 
the persistence of his symptoms and inadequate 
relief with various forms of treatment he was 
referred to our institution. He presented to us 
with sudden worsening of dyspnea, cough with 
thick golden brown casts in sputum, along with 
left sided chest pain. On examination there were 
signs of volume loss and breath sounds were 
absent on the left side. Chest radiogram showed 
left sided collapse (Fig. 3A). Routine investiga-
tions were significant for eosinophilia of 3340 
cells/µL. Fiberoptic bronchoscopy was performed 
which revealed blockage of left main bronchus by 
thick mucus plug and necrotic debris sticking to 
underlying inflamed mucosa. Bronchial aspirate 
and endobronchial biopsy showed eosinophilia 
(48%) with acute on chronic infiltrate and Charcot 
Leyden crystals with PAS +ve branching fungal 
hyphae admixed in necrotic debris. Bronchial 
aspirate was negative for acid fast bacilli and 
malignant cells. Further, patient was evaluated 
for ABPA and was found to be positive for both 
type 1 and type 3 reactions (Table 1). Spirometry 
showed no airflow limitation with forced expira-
tory volume in 1 second (FEV1) of 1.94 litres (78% 
of predicted), forced vital capacity (FVC) of 2.56 
litres (83% of predicted) and FEV1/FVC of 95% of 
predicted. A repeat chest radiogram showed full 
expansion of the left side of chest (Fig. 3B). HRCT 
showed bilateral central bronchiectasis with areas 
of mucous plugging in the left lung (Fig. 4). Thus, 
diagnosis of ABPA without bronchial asthma 
was established and patient was started on oral 
prednisolone and itraconazole 200 mg/day. He 
was followed up regularly with improvement in 
symptoms and a fall in total serum IgE to 939 
IU/ml from the initial levels of 1930 IU/ml. The 
dose of steroid was tapered off and total IgE level 
reached a plateau of 909 IU/ml after 7 months of 
treatment.
Case 3
45-year-old non-smoker chemist presented 
with complaints of episodic breathlessness and 
wheeze for 5 years which were persistent for 
one year prior to presentation. On examination, 
vitals were within normal range and auscultation 
revealed decreased breath sounds in the right 
mammary area and inspiratory crepitations. On 
chest radiogram, right middle lobe collapse was 
present (Fig. 5A). HRCT lung showed collapse of 
right middle lobe (Fig. 6A, B). Fibreoptic bron-
choscopy was performed which revealed right 
middle lobe medial segment irregular narrowing 
and transbronchial lung biopsy showed chronic 
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Figure 4. High resolution computed tomography of the lung of patient in Case 2 showing bronchiectasis and mucus plugging
BA
Figure 5. Chest radiogram of the patient in case 3, showing (A) Collapsed right middle lobe at presentation; (B) Re-expanded right middle lobe 
after treatment
sub epithelial inflammation. Computed tomog-
raphy guided fine needle aspiration was done 
which showed liquid necrotic material only. 
Patient was investigated and found positive for 
ABPA (Table 1). Thus, diagnosis of ABPA was es-
tablished and patient was started on oral steroids. 
He was followed up regularly with improvement 
in symptoms and a fall in total IgE levels to 1024 
IU/ml from initial level of 8046 IU/ml. A repeat 
chest roentgenogram and chest HRCT  showed 
re-expansion of the middle lobe and empty dilated 
bronchus (Fig. 5B, 6C, D). 
Discussion
ABPA is often indolent and may be present 
for years before diagnosis. When diagnosis is 
made early and treatment with prednisolone is 
started, irreversible lung damage can be preven-
ted. Prednisolone controls the asthma and causes 
the sputum (which is the culture medium for 
Aspergillus fumigatus) to disappear. It eliminates 
the inflammatory reactions of the bronchi and 
lung parenchyma so that the patient’s condition 
improves clinically [10].
The increasing frequency with which the 
diagnosis of ABPA is being made is probably the 
result of increasing recognition of the disease 
entity, and perhaps some liberalization of the 
criteria required for diagnosis [11]. The diagno-
stic criteria for ABPA are divided into major and 
minor ones. The major criteria includes asthma, 
fleeting shadows on chest radiograms, immediate 
cutaneous reactivity to Aspergillus fumigatus, 






Figure 6. High resolution computed tomography of the lung of patient in case 3 (A, B) Collapsed medial segment of right middle lobe at presentation 
(C, D) Re-expanded medial segment of right middle after treatment
elevated total serum IgE, precipitating antibo-
dies against Aspergillus fumigatus, peripheral 
blood eosinophilia, elevated serum IgE and IgG 
to Aspergillus fumigatus, central/proximal bron-
chiectasis with normal tapering of distal bronchi. 
The minor criteria are expectoration of golden 
brownish sputum plugs, positive sputum culture 
for Aspergillus species, and delayed skin reactivity 
to Aspergillus fumigatus. A minimum essential 
set of criteria has also been advocated that inc-
ludes asthma, immediate cutaneous reactivity to 
Aspergillus fumigatus and central bronchiectasis 
in the absence of distal bronchiectasis, elevated 
total IgE, specific IgE against Aspergillus fumigatus 
[12, 13].
A literature search for ABPA presenting as 
opaque hemithorax could yield only four such 
cases [14−16]. In a case series of five patients of 
lung collapse caused by ABPA in non-asthmatic 
by Berkin et al., two cases presented as opaque 
hemithorax [14]. A case of total collapse of right 
lung in a patient with ABPA has been reported 
from Japan by Nomura et al in a 29 year old man 
with bronchial asthma [15]. Agarwal et al de-
scribed a 22-year-old female without any prior 
respiratory symptom history who presented with 
respiratory failure secondary to left lung collapse, 
necessitating rigid bronchoscopy for diagnosis 
and management of ABPA [16]. In eight out of 
the nineteen cases of ABPA in non-asthmatic 
patients [14, 17−19], bronchogenic carcinoma 
was initially suspected due to abnormality in 
the chest roentgenogram (mostly atelectasis), 
but bronchoscopy revealed typical mucus plugs 
containing macrophages, several eosinophils, 
fungal hyphae, scaled-off epithelium (crushman 
spirals) and calcium oxalate crystals [20]. The mi-
croscopic finding of mucoid impaction of bronchi 
in conjunction with non-invasive fungal hyphae 
is highly suggestive of ABPA [20]. Many times 
these patients are confused with tuberculosis 
and repeatedly treated with anti-tuberculosis 
drugs [21].
The radiographs of 100 patients with ABPA 
were examined to assess the type and distribution 
of abnormalities seen during long-term follow-up 
by Phelan et al [22]. Lobar shrinkage occurred 
almost exclusively in the upper zones but other 
abnormalities were distributed throughout both 
lungs. Bronchial wall thickening was the com-
monest lesion observed and was usually a per-
manent finding. Consolidation was commonest 
in the perihilar regions. Episodes of transient col-
lapse were segmental, lobar or involved a whole 
Pneumonologia i Alergologia Polska 2015, vol. 83, no. 2, pages 144–150 
150 www.pneumonologia.viamedica.pl
lung. Permanent collapse was always segmental. 
Massive shadowing, band shadows and ‘gloved 
fingers’ were seen less frequently than expected 
and cavitation was rare. In some patients the 
chest radiograph was normal between exacer-
bations of the disease. It should also be consi-
dered that although pulmonary infiltrates and 
segmental collapse are the usual radiological 
picture, it can rarely present as lung collapse 
as in our case.
On computed tomography, the mucoid im-
paction of the bronchial tree generally shows 
slightly hyper-hydric density [20]. Computed 
tomography has a sensitivity of 83% and a specifi-
city of 92% in detecting central bronchiectasis in 
patients with ABPA [23]. Computed tomography 
appearances can be sub-divided into bronchial, 
parenchymal and pleural abnormalities. Bron-
chial abnormalities include central bronchiecta-
sis, dilated and totally occluded bronchi, air-fluid 
levels within the dilated bronchi, bronchial wall 
thickening and parallel-line shadows. Parenchy-
mal abnormalities, which have a predilection for 
upper lobes, include consolidation, collapse and 
parenchymal scarring. Parenchymal lesions can 
extend up to the pleura [24].
Itraconazole is a potential adjunctive treat-
ment for ABPA. Itraconazole treatment of subjects 
with stable ABPA reduces eosinophilic airway 
inflammation, systemic immune activation, and 
exacerbations [25].
Conclusions
The present case series highlights the need 
for aggressive approach in diagnosing this treata-
ble condition in cases presenting as segmental or 
total lung collapse even in patients without prior 
history of bronchial asthma. The condition has 
a good prognosis if detected early. The collapse can 
be managed by aggressive pulmonary toileting to 
cause mobilization of secretions by physiothera-
py, postural drainage and/or bronchoscopy along 
with treatment with drugs like corticosteroids 
and/or antifungal agents. We hereby recommend 
that ABPA should be kept as a differential dia-
gnosis of lung collapse.
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